Merck Announces Second-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Merck (MRK) Tops Analyst Estimates on Strong Keytruda, Gardasil, and Bridion Sales
July 28, 2022 2:03 PM EDTMerck's (NYSE: MRK) shares dipped in the early part of Thursday's session after it reported second-quarter earnings.
Profit and revenue topped analyst expectations, but the company's shares fell as low as $87.42 after guidance disappointed investors. The stock has since regained the majority of its initial losses.
Merck posted earnings of $1.87, $0.19 better than the analyst estimate of... More
Merck (MRK) Tops Q2 EPS by 19c; Raises and Narrows FY Sales Guidance, Narrows EPS
July 28, 2022 6:37 AM EDTMerck (NYSE: MRK) reported Q2 EPS of $1.87, $0.19 better than the analyst estimate of $1.68. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.83 billion.
GUIDANCE:
Merck sees FY2022 EPS of $7.25-$7.35, versus the consensus of $7.36. Merck sees... More
